Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Iida

Showing results (591-600 of 640) with videos related to

Pageof 64
Sort By:
Oncogene|July 1, 1992
Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocationM Seto, K Yamamoto, S Iida, et al.
Cancer|January 1, 1991
Prognostic factors in yolk sac tumors of the ovary. A clinicopathologic analysis of 29 casesM Kawai, T Kano, Y Furuhashi, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1990
Anti-human immunodeficiency virus type 1 activities and pharmacokinetics of novel 6-substituted acyclouridine derivativesM Baba, E De Clercq, S Iida, et al.
Biochemical and Biophysical Research Communications|September 30, 1992
Polyclonal antibody against an inducible form of nitric oxide synthase purified from the liver of rats treated with Propionibacterium acnes and lipopolysaccharideH Ohshima, I M Brouet, T Bandaletova, et al.
British Journal of Cancer|July 3, 2008
MAGE-A protein and MAGE-A10 gene expressions in liver metastasis in patients with stomach cancerS Suzuki, K Sasajima, Y Sato, et al.
FEBS Letters|October 13, 1999
A human homolog of Drosophila warts tumor suppressor, h-warts, localized to mitotic apparatus and specifically phosphorylated during mitosisY Nishiyama, T Hirota, T Morisaki, et al.
Blood Cancer Journal|March 11, 2017
Randomized phase 3 study of elotuzumab for relapsed or refractory multiple myeloma: ELOQUENT-2 Japanese patient subanalysisK Suzuki, K Sunami, K Ohashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 15, 1998
[Intra-arterial injection therapy of mitoxantrone for locally advanced breast cancer]W Ichikawa, T Osanai, C Shimizu, et al.
Leukemia|August 11, 2007
Proteome analyses of the growth inhibitory effects of NCH-51, a novel histone deacetylase inhibitor, on lymphoid malignant cellsT Sanda, T Okamoto, Y Uchida, et al.
Steroids|September 24, 1999
Preparation of specific antisera to 15alpha-hydroxyestrogensE Suzuki, M Nakagomi, M Hashimoto, et al.
Pageof 64

Showing results (591-600 of 640) with videos related to

Sort By:
Pageof 64
Oncogene|July 1, 1992
Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocationM Seto, K Yamamoto, S Iida, et al.
Cancer|January 1, 1991
Prognostic factors in yolk sac tumors of the ovary. A clinicopathologic analysis of 29 casesM Kawai, T Kano, Y Furuhashi, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1990
Anti-human immunodeficiency virus type 1 activities and pharmacokinetics of novel 6-substituted acyclouridine derivativesM Baba, E De Clercq, S Iida, et al.
Biochemical and Biophysical Research Communications|September 30, 1992
Polyclonal antibody against an inducible form of nitric oxide synthase purified from the liver of rats treated with Propionibacterium acnes and lipopolysaccharideH Ohshima, I M Brouet, T Bandaletova, et al.
British Journal of Cancer|July 3, 2008
MAGE-A protein and MAGE-A10 gene expressions in liver metastasis in patients with stomach cancerS Suzuki, K Sasajima, Y Sato, et al.
FEBS Letters|October 13, 1999
A human homolog of Drosophila warts tumor suppressor, h-warts, localized to mitotic apparatus and specifically phosphorylated during mitosisY Nishiyama, T Hirota, T Morisaki, et al.
Blood Cancer Journal|March 11, 2017
Randomized phase 3 study of elotuzumab for relapsed or refractory multiple myeloma: ELOQUENT-2 Japanese patient subanalysisK Suzuki, K Sunami, K Ohashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 15, 1998
[Intra-arterial injection therapy of mitoxantrone for locally advanced breast cancer]W Ichikawa, T Osanai, C Shimizu, et al.
Leukemia|August 11, 2007
Proteome analyses of the growth inhibitory effects of NCH-51, a novel histone deacetylase inhibitor, on lymphoid malignant cellsT Sanda, T Okamoto, Y Uchida, et al.
Steroids|September 24, 1999
Preparation of specific antisera to 15alpha-hydroxyestrogensE Suzuki, M Nakagomi, M Hashimoto, et al.
Pageof 64